Cart
sales@molnova.com
Torbafylline
CAS No. 105102-21-4
Torbafylline( —— )
Catalog No. M36118 CAS No. 105102-21-4
Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 182 | In Stock |
|
| 10MG | 274 | In Stock |
|
| 25MG | 448 | In Stock |
|
| 50MG | 603 | In Stock |
|
| 100MG | 826 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTorbafylline
-
NoteResearch use only, not for human use.
-
Brief DescriptionTorbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway.
-
DescriptionTorbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE | PI3K | cAMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105102-21-4
-
Formula Weight338.4
-
Molecular FormulaC16H26N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OCC)N1C2=C(N(C)C(=O)N(CCCCC(C)(C)O)C2=O)N=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-(Hydroxymethyl)pyr...
2-Pyridinylmethanol is an organic compound.
-
Carbodenafil
Carbodenafil is a Sildenafil related compound found in healthy foods. Sildenafil is a PDE5 inhibitor (IC50: 5.22 nM).
-
Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
